It delivers biomarkers—estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) that categorizes BC into five subtypes (Figure 2B): luminal A and B, HER2 enriched, triple-negative or basal-like (BL), and normal-like BC. Here, PGR is linked to breast cancer.